Erick Lucera, Chief Financial Officer at Dyne Therapeutics, Inc. (DYN), sold 2,362 shares at $20.37 ($48K) on 2026-06-25, disclosed to the SEC on 2026-06-26.
Open-market sale of $48k DYN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DYN | SELL | 2026-04-03 | $107K | — | Filing → |
| EDIT | SELL | 2025-03-05 | $7K | — | Filing → |
| XAIR | BUY | 2024-08-15 | $16K | — | Filing → |